Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 10.85 EUR -8.71% Market Closed
Market Cap: 8B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Roivant Sciences Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Roivant Sciences Ltd
Total Equity Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Roivant Sciences Ltd
F:87S
Total Equity
$6B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Total Equity
$236.2m
CAGR 3-Years
324%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Total Equity
$111.5m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Total Equity
$831m
CAGR 3-Years
69%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Total Equity
ÂŁ368.8m
CAGR 3-Years
88%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Total Equity
ÂŁ548.2m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
7%

See Also

What is Roivant Sciences Ltd's Total Equity?
Total Equity
6B USD

Based on the financial report for Mar 31, 2024, Roivant Sciences Ltd's Total Equity amounts to 6B USD.

What is Roivant Sciences Ltd's Total Equity growth rate?
Total Equity CAGR 3Y
49%

Over the last year, the Total Equity growth was 416%. The average annual Total Equity growth rates for Roivant Sciences Ltd have been 49% over the past three years .

Back to Top